Abstract
It is still not fully understood to what extent intronic sequences contribute to the regulation of the different forms of alternative splicing. We are interested in the regulation of alternative cassette exon events, such as exon inclusion and exon skipping. We investigated these events by comparative genomic analysis of human and mouse in five experimentally well-characterized genes, neurofibromatosis 1 (NF1), cystic fibrosis transmembrane conductance regulator (CFTR), period 3 (PER3), cysteinyl-tRNA synthetase (CARS) and synaptotagmin 7 (SYT7). In NF1, high intron identity around the 52 constitutive and four alternatively skipped NF1 exons is restricted to the close vicinity of the exons. In contrast, we found on average high conservation of intron sequences over 300 base pairs up- and downstream of the five alternatively included NF1 exons. The investigation of alternatively included exons in CFTR, PER3, CARS and SYT7 supported this finding. In contrast, the mean intron identities around the alternatively skipped exons in CTFR and NF1 do not differ considerably from those around the constitutive exons. In these genes, the difference in intron conservation could point to a difference between the regulation of alternative exon inclusion and alternative exon skipping or constitutive exon splicing. Additional genome-wide investigations are necessary to elucidate to what extent our finding can be generalized.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Zhang MQ : Computational prediction of eukaryotic protein-coding genes. Nat Rev Genet 2002; 3: 698–709.
Cartegni L, Chew SL, Krainer AR : Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 2002; 3: 285–298.
Ladd AN, Cooper TA : Finding signals that regulates alternative splicing in the postgenomic era. Genome Biol 2002; 3: (reviews0008.1-0008.16.).
Nogués G, Kadener S, Cramer P, Bentley D, Kornblihtt AR : Transcriptional activators differ in their abilities to control alternative splicing. J Biol Chem 2002; 277: 43110–43114.
Clark F, Thanaraj TA : Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human. Hum Mol Genet 2002; 11: 451–464.
Loots GG, Locksley RM, Blankespoor CM et al: Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 2000; 288: 136–140.
Mouse Genome Sequencing Consortium: Initial sequencing and comparative analysis of the mouse genome. Nature 2002; 420: 520–562.
Shen MH, Harper PS, Upadhyaya M : Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet 1996; 33: 2–17.
Cichowski K, Jacks T : NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001; 104: 593–604.
Kaufmann D, Muller R, Kenner O et al: The N-terminal splice product NF1-10a-2 of the NF1 gene codes for a transmembrane segment. Biochem Biophys Res Commun 2002; 294: 496–503.
Mantani A, Wakasugi S, Yokota Y, Abe K, Ushio Y, Yamamura K : A novel isoform of the neurofibromatosis type-1 mRNA and a switch of isoforms during murine cell differentiation and proliferation. Gene 1994; 148: 245–251.
Vandenbroucke I, Vandesompele J, De Paepe A, Messiaen L : Quantification of NF1 transcripts reveals novel highly expressed splice variants. FEBS Lett 2002; 522: 71–76.
Wimmer K, Eckart M, Rehder H, Fonatsch C : Illegitimate splicing of the NF1 gene in healthy individuals mimics mutation-induced splicing alterations in NF1 patients. Hum Genet 2000; 106: 311–313.
Kaufmann D, Leistner W, Kruse P et al: Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2. Cancer Res 2002; 62: 1503–1509.
Thomson SA, Wallace MR : 2002) RT-PCR splicing analysis of the NF1 open reading frame. Hum Genet 2002; 110: 495–502.
Jensen KB, Dredge BK, Stefani G et al: Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 2000; 25: 359–371.
Sirand-Pugnet P, Durosay P, Brody E, Marie J : An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken beta-tropomyosin pre-mRNA. Nucleic Acids Res 1995; 23: 3501–3507.
Chou MY, Underwood JG, Nikolic J, Luu MH, Black DL : Multisite RNA binding and release of polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol Cell 2000; 5: 949–957.
Carlo T, Sierra R, Berget SM : A 5′ splice site-proximal enhancer binds SF1 and activates exon bridging of a microexon. Mol Cell Biol 2000; 20: 3988–3995.
Modafferi EF, Black DL : A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon. Mol Cell Biol 1997; 17: 6537–6545.
Chabot B, Blanchette M, Lapierre I, La Branche H : An intron element modulating 5′ splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol Cell Biol 1997; 17: 1776–1786.
Jin W, Bi W, Huang ESC, Cote GJ : Glioblastoma cell-specific expression of fibroblast growth factor receptor-1β requires an intronic repressor of RNA splicing. Cancer Res 1999; 59: 316–319.
Pret AM, Balvay L, Fiszman MY : Regulated splicing of an alternative exon of beta-tropomyosin pre-mRNAs in myogenic cells depends on the strength of pyrimidine-rich intronic enhancer elements. DNA Cell Biol 1999; 18: 671–683.
Blanchette M, Chabot B : Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J 1999; 18: 1939–1952.
del Gatto F, Plet A, Gesnel MC, Fort C, Breathnach R : Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon. Mol Cell Biol 1997; 17: 5106–5116.
Lou H, Yang Y, Cote GJ, Berget SM, Gagel RF : An intron enhancer containing a 5′ splice site sequence in the human calcitonin/calcitonin gene-related paptide gene. Mol Cell Biol 1995; 15: 7135–7142.
Markovtsov V, Nikolic JM, Goldman JA, Turck CW, Chou MY, Black DL : Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol Cell Biol 2000; 20: 7463–7479.
Standiford DM, Sun WT, Davis MB, Emerson Jr CP : Positive and negative intronic regulatory elements control muscle-specific alternative exon splicing of drosophila myosin heavy chain transcripts. Genetics 2001; 157: 259–271.
Cooper TA : Muscle-specific splicing of a heterologous exon mediated by a single muscle-specific splicing enhancer from the cardiac troponin T gene. Mol Cell Biol 1998; 18: 4519–4525.
Zhang MQ : Identification of human gene core promoters in silico. Genome Res 1998; 8: 319–326.
Knudsen S : Promoter2.0: for the recognition of Pol II promoter sequences. Bioinformatics 1999; 15: 356–361.
Boyd DC, Turner PC, Watkins NJ, Gerster T, Murphy S : Functional redundancy of promoter elements ensures efficient transcription of the human 7SK gene in vivo. J Mol Biol 1995; 253: 677–690.
Weinstein LB, Steitz JA : Guided tours: from precursor snoRNA to functional snoRNA. Curr Opin Cell Biol 1999; 11: 378–384.
Hedges SB, Kumar S : Vertebrate genomes compared. Science 2002; 297: 1283–1285.
Melo CA, Serra C, Stoyanova V et al: Alternative splicing of a previously unidentified CFTR exon induces an in-frame stop codon 5′ of the R region. FEBS Lett 1993; 329: 159–162.
Zylka MJ, Shearman LP, Weaver DR, Reppert SM : Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron 1998; 20: 1103–1110.
Kim JE, Kim KH, Lee SW, Seol W, Shiba K, Kim S : An elongation factor-associating domain is inserted into human cysteinyl-tRNA synthetase by alternative splicing. Nucleic Acids Res 2000; 28: 2866–2872.
Fukuda M, Ogata Y, Saegusa C, Kanno E, Mikoshiba K : Alternative splicing isoforms of synaptotagmin VII in the mouse, rat and human. Biochem J 2002; 365: 173–180.
Hull J, Shackleton S, Harris A : Analysis of mutations and alternative splicing patterns in the CFTR gene using mRNA derived from nasal epithelial cells. Hum Mol Genet 1994; 3: 1141–1146.
Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call MK, Housman DE : Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 1991; 88: 9618–9622.
Ellenrieder C, Bartosch B, Lee GY et al: The long form of CDK2 arises via alternative splicing and forms an active protein kinase with cyclins A and E. DNA and Cell Biol 2001; 20: 413–423.
Jaworski C, Sperbeck S, Graham C, Wistow G : Alternative splicing of Pax6 in bovine eye and evolutionary conservation of intron sequences. Biochem Biophys Res Commun 1997; 240: 196–202.
Modrek B, Resch A, Grasso C, Lee C : Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res 2001; 29: 2850–2859.
Zavolan M, Van Nimwegen E, Gaasterland T : Splice variation in mouse full-length cDNAs identified by mapping to the mouse genome. Genome Res 2002; 12: 1377–1385.
Xuan Z, Wang J, Zhang MQ : Computational comparison of two mouse draft genomes and the human golden path. Genome Biol 2002; 4: R1.
Coleman TP, Roesser JR : RNA secondary structure: an important cis-element in rat calcitonin/CGRP pre-messenger RNA splicing. Biochemistry 1998; 37: 15941–15950.
Li AW, Murphy PR : Expression of alternatively spliced FGF-2 antisense RNA transcripts in the central nervous system: regulation of FGF-2 mRNA translation. Mol Cell Endocrinol 2000; 170: 233–242.
Thenie AC, Gicquel IM, Hardy S et al: Identification of an endogenous RNA transcribed from the antisense strand of the HFE gene. Hum Mol Gen 2001; 10: 1859–1866.
Rettenberger G, Klett C, Zechner U et al: ZOO-FISH analysis: cat and human karyotypes closely resemble the putative ancestral mammalian karyotype. Chromosome Res 1995; 13: 479–486.
Acknowledgements
We thank D Viskochil for critical discussion concerning our observations. The technical assistance of A Siegel, B Dieske, H Goetz and E Winkler is also gratefully acknowledged. Furthermore, we thank H Lattke, who died recently and R Mueller for technical advice. This work was supported by the Deutsche Krebshilfe (BB, BD) and Graduate College 460 of University Ulm (OK).
Author information
Authors and Affiliations
Corresponding author
Additional information
Online Mendelian Inheritance in Man (OMIM) (http://www3.ncbi.nlm.nih.gov/Omim/); Promoter 2.0 Homepage (http://www.cbs.dtu.dk/services/Promoter/)
Rights and permissions
About this article
Cite this article
Kaufmann, D., Kenner, O., Nurnberg, P. et al. In NF1, CFTR, PER3, CARS and SYT7, alternatively included exons show higher conservation of surrounding intron sequences than constitutive exons. Eur J Hum Genet 12, 139–149 (2004). https://doi.org/10.1038/sj.ejhg.5201098
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.ejhg.5201098
Keywords
This article is cited by
-
Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation
Scientific Reports (2021)
-
Activation of Src and transformation by an RPTPα splice mutant found in human tumours
The EMBO Journal (2011)
-
Alternative splicing and RNA selection pressure — evolutionary consequences for eukaryotic genomes
Nature Reviews Genetics (2006)
